Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Mol Cancer Res. 2019 Sep 16;18(1):20–26. doi: 10.1158/1541-7786.MCR-19-0262

Table 1:

Comparison of key parallel factors for invasive mammalian species eradication and cancer treatment, and the relative impact of each factor on treatment success.

Invasive mammals Cancer Relative impact on treatment success
Distinctiveness between host/invader High: Millions of coding point mutations between invader and native species Low: <1000 coding point mutations between tumor and normal cells Lower treatment specificity and success against cancer than treatments against mammalian island invaders.
Genetic diversity among similarly treated species Genetic differences are high: millions of coding mutations between different species. Genetic differences are low: <100,000 coding germline differences between patients and <1000 coding mutations between patient tumor / germline. Treatment response varies little between mammalian species but varies much between different cancer types.
Invader intrapopulation heterogeneity Low: small populations (~103 for rats on most islands) and low mutation rates High: large number of cells (~109) and high mutation rates Cancers have more opportunities for evolution of resistance.
Invader environment interactions Decoupling of invader genetics and ecological environment Primary tumor genetics evolve in a fixed microenvironment, followed by decoupling at metastasis. Microenvironment may be more targetable in cancer, especially for primary tumors. Rats are robust across island environments.